Treatment of clinical mastitis is the most common reason that antimicrobials are given to
adult dairy cows and careful consideration of treatment protocols is necessary to ensure …

Periparturient diseases continue to be the greatest challenge to both farmers and dairy
cows. They are associated with a decrease in productivity, lower profitability, and a negative …

No nationwide studies of the incidence rate of clinical mastitis (IRCM) have been conducted
in Canada. Because the IRCM and distribution of mastitis-causing bacteria may show …

Knowledge of the incidence of clinical mastitis (CM) and the distribution of pathogens
involved is essential for development of prevention and control programs as well as …

In recent years, the US dairy industry has experienced significant demographic changes,
with an increase in the number of large herds. The objectives of the present study were to …

The objective of this multi-state, multi-herd clinical trial was to evaluate the efficacy of using
an on-farm culture system to guide strategic treatment decisions in cows with clinical …

The objectives of this study were to characterize 60-d outcomes after treatment of mild
(abnormal milk) and moderate (abnormal milk and abnormal udder) cases of clinical mastitis …

Antimicrobials are frequently used for treatment of bovine mastitis and few studies have
examined modern treatment strategies on large US dairy farms. The objective of this study …

Mastitis occurs in numerous species. Antimicrobial agents are used for treatment of
infectious mastitis in dairy cattle, other livestock, companion animals, and humans. Mastitis …

Drug treatment of mastitis during lactation remains common, as does treatment of cows at
drying off. Our understanding of the disease, the causative pathogens, and the rationale for …